Fetal exposure to a mixture of endocrine‐disrupting chemicals and biomarkers of male fecundity: A population‐based cohort study
Results suggest that fetal exposure to an overall mixture of EDCs may be adversely associated with several biomarkers of male fecundity, but findings are also compatible with null associations. These associations, if true, appeared to be driven by PFAS, but misclassification due to a single measurement of the phthalate metabolites and triclosan may have attenuated the results.
Authors
- Sandra Søgaard Tøttenborg (ORCID: https://orcid.org/0000-0001-7742-4360)
- Cecilia Høst Ramlau‐Hansen (ORCID: https://orcid.org/0000-0003-3296-0121)
- Zeyan Liew (ORCID: https://orcid.org/0000-0002-9424-7869)
- Esben Meulengracht Flachs (ORCID: https://orcid.org/0000-0002-2252-8426)
- Gunnar Toft
- Sidsel Dan Hull (ORCID: https://orcid.org/0000-0001-6198-3256)
- Karin Sørig Hougaard (ORCID: https://orcid.org/0000-0002-3386-0512)
- Christian H. Lindh (ORCID: https://orcid.org/0000-0001-7435-9890)
- Lauren Anne Wise (ORCID: https://orcid.org/0000-0003-2138-3752)
- Allen J. Wilcox (ORCID: https://orcid.org/0000-0002-3376-1311)
- Kajsa Kirstine Ugelvig Petersen
- Jens Peter Bonde
Institutions
- Boston University (US)
- University of Copenhagen (DK)
- Steno Diabetes Centers (DK)
- Lund University (SE)
- Aarhus University (DK)
- Frederiksberg Hospital (DK)
- Aarhus University Hospital (DK)
- Copenhagen University Hospital (DK)
- National Institute of Environmental Health Sciences (US)
- Yale New Haven Health System (US)
- National Research Centre for the Working Environment (DK)
Publication Details
- Journal
- Andrology
- Published
- 2025-04-12
- DOI
- https://doi.org/10.1111/andr.70039
- Primary Topic
- Effects and risks of endocrine disrupting chemicals
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Dagmar Marshalls Fond
- European Commission
- Ferring
- Lundbeckfonden
- Danmarks Frie Forskningsfond
- Region Hovedstaden
- A.P. Møller og Hustru Chastine Mc-Kinney Møllers Fond til almene Formaal
- Helsefonden
- Novo Nordisk Fonden
- H. Lundbeck A/S